| Bioactivity | TAT-Gap19, a Cx mimetic peptide, is a specific connexin43 hemichannel (Cx43 HC) inhibitor. TAT-Gap19 does not inhibits the corresponding Cx43 GJCs. TAT-Gap19 traverses the blood-brain barrier and alleviate liver fibrosis in mice[1][2][3]. | ||||||
| Name | TAT-Gap19 | ||||||
| CAS | 1507930-54-2 | ||||||
| Shortening | YGRKKRRQRRRKQIEIKKFK | ||||||
| Formula | C119H212N46O26 | ||||||
| Molar Mass | 2703.25 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
TAT-Gap19
CAS: 1507930-54-2 F: C119H212N46O26 W: 2703.25
TAT-Gap19, a Cx mimetic peptide, is a specific connexin43 hemichannel (Cx43 HC) inhibitor. TAT-Gap19 does not inhibits t
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.